Skip to Main Navigation
Skip to Page Content

COVID-19 is an emerging, rapidly evolving situation.

Get the latest public health information from CDC and research information from NIH.

U.S. flag

An official website of the United States government

Dot gov

The .gov means it's official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Share This:
https://ntp.niehs.nih.gov/go/2532

TDMS Study 05156-06 Pathology Tables

NTP Experiment-Test: 05156-06         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                    COBALT SULFATE HEPTAHYDRATE                                Date: 07/03/96
Route: RESPIRATORY EXPOSURE WHOLE BODY                                                                            Time: 10:11:26

                                                           CORE STUDY




       Facility:  Battelle Northwest

       Chemical CAS #:  10026-24-1

       Lock Date:  07/12/94

       Cage Range:  All

       Reasons For Removal:    All

       Removal Date Range:     All

       Treatment Groups:       Include All


































a  Number of animals examined microscopically at site and number of animals with lesion

                                                              Page   1

NTP Experiment-Test: 05156-06         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                    COBALT SULFATE HEPTAHYDRATE                                Date: 07/03/96  
Route: RESPIRATORY EXPOSURE WHOLE BODY                                                                            Time: 10:11:26  
____________________________________________________________________________________________________________________________________
         B6C3F1 MICE FEMALE                        CONTROL      0.3          1.0          3.0                                       
                                                                MG/M3        MG/M3        MG/M3                                     
____________________________________________________________________________________________________________________________________
DISPOSITION SUMMARY                                                                                                                 
  Animals Initially In Study                          50           50           50           50                                     
  Early Deaths                                                                                                                      
    Natural Death                                      5            3            5            6                                     
    Moribund Sacrifice                                11           10           13           16                                     
  Survivors                                                                                                                         
    Terminal Sacrifice                                34           37           32           28                                     
  Animals Examined Microscopically                    50           50           50           50                                     
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 ALIMENTARY SYSTEM                                                                                                                  
                                                                                                                                    
   Intestine Large, Cecum                             (49)         (49)         (48)         (47)                                   
      Inflammation                                                               1 (2%)                                             
   Intestine Small, Ileum                             (48)         (48)         (47)         (45)                                   
      Peyer's Patch, Hyperplasia, Lymphoid                                       1 (2%)                                             
   Liver                                              (50)         (50)         (50)         (49)                                   
      Basophilic Focus                                              1 (2%)                                                          
      Clear Cell Focus                                 2 (4%)       1 (2%)       1 (2%)       1 (2%)                                
      Clear Cell Focus, Multiple                                                              1 (2%)                                
      Cyst                                                                       1 (2%)       1 (2%)                                
      Eosinophilic Focus                               9 (18%)      7 (14%)      8 (16%)      9 (18%)                               
      Eosinophilic Focus, Multiple                                                            1 (2%)                                
      Hematopoietic Cell Proliferation                              1 (2%)                    1 (2%)                                
      Hemorrhage                                                    1 (2%)                                                          
      Infiltration Cellular, Lymphocyte                3 (6%)       2 (4%)       1 (2%)       1 (2%)                                
      Infiltration Cellular, Mixed Cell                             1 (2%)                                                          
      Inflammation, Chronic                            6 (12%)      1 (2%)       1 (2%)       2 (4%)                                
      Karyomegaly                                      4 (8%)       2 (4%)                    1 (2%)                                
      Mineralization                                                             1 (2%)                                             
      Necrosis                                         1 (2%)                                                                       
      Necrosis, Focal                                  3 (6%)       1 (2%)       2 (4%)       2 (4%)                                
      Regeneration                                     1 (2%)                                                                       
      Thrombosis                                                                              1 (2%)                                
      Vacuolization Cytoplasmic                                     1 (2%)                                                          
      Vacuolization Cytoplasmic, Diffuse                                         1 (2%)       1 (2%)                                
      Oval Cell, Hyperplasia                           2 (4%)       1 (2%)                                                          
      Serosa, Fibrosis                                                                        1 (2%)                                
   Mesentery                                          (10)         (12)         (8)          (7)                                    
      Angiectasis                                      1 (10%)                                                                      
      Hemorrhage                                                                              1 (14%)                               
      Infiltration Cellular, Lymphocyte                             1 (8%)                                                          
      Inflammation, Chronic                                         1 (8%)                                                          
      Fat, Necrosis                                    7 (70%)      8 (67%)      7 (88%)      5 (71%)                               
   Pancreas                                           (50)         (50)         (49)         (49)                                   
      Infiltration Cellular, Lymphocyte                                          1 (2%)                                             
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    2                                                              
NTP Experiment-Test: 05156-06         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                    COBALT SULFATE HEPTAHYDRATE                                Date: 07/03/96  
Route: RESPIRATORY EXPOSURE WHOLE BODY                                                                            Time: 10:11:26  
____________________________________________________________________________________________________________________________________
         B6C3F1 MICE FEMALE                        CONTROL      0.3          1.0          3.0                                       
                                                                MG/M3        MG/M3        MG/M3                                     
____________________________________________________________________________________________________________________________________
                                                                                                                                    
ALIMENTARY SYSTEM - CONT                                                                                                            
      Inflammation, Chronic                            1 (2%)       1 (2%)                                                          
      Acinus, Atrophy                                  1 (2%)       2 (4%)                    3 (6%)                                
      Duct, Cyst                                       1 (2%)       2 (4%)       1 (2%)                                             
   Stomach, Forestomach                               (50)         (50)         (49)         (50)                                   
      Cyst                                                          1 (2%)                                                          
      Hyperplasia, Squamous                            1 (2%)       3 (6%)       1 (2%)       3 (6%)                                
      Inflammation                                                  2 (4%)                                                          
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 CARDIOVASCULAR SYSTEM                                                                                                              
                                                                                                                                    
   Heart                                              (50)         (50)         (50)         (50)                                   
      Mineralization                                   1 (2%)                                                                       
      Artery, Inflammation, Chronic                    1 (2%)                    1 (2%)                                             
      Epicardium, Fibrosis                                                                    1 (2%)                                
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 ENDOCRINE SYSTEM                                                                                                                   
                                                                                                                                    
   Adrenal Cortex                                     (50)         (50)         (49)         (50)                                   
      Accessory Adrenal Cortical Nodule                                                       1 (2%)                                
      Angiectasis                                      1 (2%)                                                                       
      Cyst, Focal                                                                1 (2%)                                             
      Degeneration, Cystic, Focal                                   1 (2%)                                                          
      Inflammation                                     1 (2%)                                 1 (2%)                                
      Vacuolization Cytoplasmic                                                  1 (2%)       1 (2%)                                
      Capsule, Hyperplasia                                                       1 (2%)                                             
   Pituitary Gland                                    (48)         (47)         (47)         (48)                                   
      Angiectasis                                      2 (4%)       5 (11%)      1 (2%)       2 (4%)                                
      Pars Distalis, Angiectasis                       1 (2%)                                                                       
      Pars Distalis, Hyperplasia                      12 (25%)      1 (2%)       7 (15%)      6 (13%)                               
   Thyroid Gland                                      (50)         (49)         (49)         (49)                                   
      Cyst                                                                       1 (2%)                                             
      Infiltration Cellular, Lymphocyte                                          1 (2%)                                             
      Inflammation                                                                            1 (2%)                                
      Follicular Cell, Hyperplasia                    20 (40%)     17 (35%)     14 (29%)     19 (39%)                               
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 GENERAL BODY SYSTEM                                                                                                                
                                                                                                                                    
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    3                                                              
NTP Experiment-Test: 05156-06         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                    COBALT SULFATE HEPTAHYDRATE                                Date: 07/03/96  
Route: RESPIRATORY EXPOSURE WHOLE BODY                                                                            Time: 10:11:26  
____________________________________________________________________________________________________________________________________
         B6C3F1 MICE FEMALE                        CONTROL      0.3          1.0          3.0                                       
                                                                MG/M3        MG/M3        MG/M3                                     
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 GENITAL SYSTEM                                                                                                                     
                                                                                                                                    
   Clitoral Gland                                     (41)         (40)         (43)         (40)                                   
      Cyst                                             1 (2%)                                                                       
      Inflammation                                     1 (2%)       1 (3%)                                                          
   Ovary                                              (48)         (49)         (49)         (48)                                   
      Angiectasis                                      1 (2%)       1 (2%)       1 (2%)                                             
      Atrophy                                                                    2 (4%)                                             
      Cyst                                             9 (19%)     12 (24%)     16 (33%)     15 (31%)                               
      Thrombosis                                                    1 (2%)                                                          
      Bilateral, Cyst                                                            1 (2%)                                             
   Uterus                                             (50)         (50)         (49)         (49)                                   
      Angiectasis                                      1 (2%)       1 (2%)       1 (2%)                                             
      Hydrometra                                                    3 (6%)       3 (6%)       2 (4%)                                
      Hyperplasia, Cystic                             37 (74%)     41 (82%)     38 (78%)     37 (76%)                               
      Inflammation                                                                            2 (4%)                                
      Inflammation, Suppurative                                     1 (2%)                                                          
      Thrombosis                                       1 (2%)                    1 (2%)       1 (2%)                                
      Cervix, Hemorrhage                                            1 (2%)                                                          
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 HEMATOPOIETIC SYSTEM                                                                                                               
                                                                                                                                    
   Bone Marrow                                        (50)         (50)         (49)         (50)                                   
      Inflammation, Chronic                                                      1 (2%)                                             
   Lymph Node                                         (3)          (6)          (3)          (4)                                    
      Hyperplasia, Lymphoid                                         1 (17%)                                                         
      Iliac, Ectasia                                                             1 (33%)                                            
      Renal, Hyperplasia, Lymphoid                                  1 (17%)                                                         
   Lymph Node, Bronchial                              (30)         (34)         (27)         (35)                                   
      Hyperplasia, Lymphoid                            1 (3%)       2 (6%)       2 (7%)       3 (9%)                                
      Infiltration Cellular, Histiocyte                                                       1 (3%)                                
   Lymph Node, Mandibular                             (37)         (37)         (36)         (36)                                   
      Hyperplasia, Lymphoid                                         1 (3%)                                                          
   Lymph Node, Mesenteric                             (46)         (45)         (46)         (44)                                   
      Hyperplasia, Lymphoid                            1 (2%)       5 (11%)      2 (4%)                                             
      Infiltration Cellular, Histiocyte                1 (2%)                                                                       
      Inflammation, Chronic                            1 (2%)                                                                       
      Necrosis                                                      1 (2%)                                                          
   Lymph Node, Mediastinal                            (41)         (36)         (28)         (34)                                   
      Hemorrhage                                                                              1 (3%)                                
      Hyperplasia, Lymphoid                            3 (7%)       5 (14%)      1 (4%)       3 (9%)                                
   Spleen                                             (50)         (50)         (49)         (49)                                   
      Hematopoietic Cell Proliferation                 3 (6%)      11 (22%)      9 (18%)      3 (6%)                                
      Hyperplasia, Lymphoid                            1 (2%)       5 (10%)      1 (2%)       2 (4%)                                
   Thymus                                             (41)         (44)         (41)         (41)                                   
      Hyperplasia, Lymphoid                            1 (2%)       1 (2%)                                                          
      Necrosis                                                                   1 (2%)                                             
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    4                                                              
NTP Experiment-Test: 05156-06         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                    COBALT SULFATE HEPTAHYDRATE                                Date: 07/03/96  
Route: RESPIRATORY EXPOSURE WHOLE BODY                                                                            Time: 10:11:26  
____________________________________________________________________________________________________________________________________
         B6C3F1 MICE FEMALE                        CONTROL      0.3          1.0          3.0                                       
                                                                MG/M3        MG/M3        MG/M3                                     
____________________________________________________________________________________________________________________________________
                                                                                                                                    
                                                                                                                                    
 INTEGUMENTARY SYSTEM                                                                                                               
                                                                                                                                    
   Mammary Gland                                      (47)         (50)         (50)         (50)                                   
      Hyperplasia                                      3 (6%)       4 (8%)       2 (4%)                                             
   Skin                                               (49)         (50)         (50)         (50)                                   
      Inflammation, Chronic                                         1 (2%)                                                          
      Inflammation, Suppurative                                                  1 (2%)                                             
      Ulcer                                                         1 (2%)       1 (2%)       1 (2%)                                
      Subcutaneous Tissue, Hemorrhage                                            1 (2%)                                             
      Subcutaneous Tissue, Inflammation, Chronic                    1 (2%)                                                          
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 MUSCULOSKELETAL SYSTEM                                                                                                             
                                                                                                                                    
   Bone                                               (50)         (50)         (50)         (50)                                   
      Fibrous Osteodystrophy                           2 (4%)       1 (2%)       1 (2%)       5 (10%)                               
      Fracture                                                                   1 (2%)       1 (2%)                                
      Maxilla, Inflammation, Chronic                                                          1 (2%)                                
   Skeletal Muscle                                                 (1)          (2)          (1)                                    
      Hemorrhage                                                                 1 (50%)                                            
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 NERVOUS SYSTEM                                                                                                                     
                                                                                                                                    
   Brain                                              (50)         (50)         (50)         (50)                                   
      Hemorrhage                                                                              1 (2%)                                
   Spinal Cord                                        (1)                                    (1)                                    
      Degeneration                                                                            1 (100%)                              
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 RESPIRATORY SYSTEM                                                                                                                 
                                                                                                                                    
   Larynx                                             (50)         (49)         (47)         (50)                                   
      Inflammation, Chronic                                                                   1 (2%)                                
      Metaplasia, Squamous                                         45 (92%)     40 (85%)     50 (100%)                              
   Lung                                               (50)         (50)         (50)         (50)                                   
      Hemorrhage                                       2 (4%)       1 (2%)                    4 (8%)                                
      Infiltration Cellular, Diffuse, Histiocyte                                              4 (8%)                                
      Infiltration Cellular, Focal, Histiocyte         2 (4%)       5 (10%)      7 (14%)     10 (20%)                               
      Inflammation, Chronic                                                      1 (2%)       1 (2%)                                
      Alveolar Epithelium, Hyperplasia                 2 (4%)       3 (6%)                    5 (10%)                               
      Bronchus, Vacuolization Cytoplasmic                           6 (12%)     31 (62%)     43 (86%)                               
      Capillary, Thrombosis, Diffuse                                                          1 (2%)                                
   Nose                                               (50)         (50)         (49)         (48)                                   
      Hemorrhage                                                                 1 (2%)                                             
      Inflammation, Chronic                                                                   1 (2%)                                
      Inflammation, Suppurative                                     1 (2%)       5 (10%)      4 (8%)                                
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    5                                                              
NTP Experiment-Test: 05156-06         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                    COBALT SULFATE HEPTAHYDRATE                                Date: 07/03/96  
Route: RESPIRATORY EXPOSURE WHOLE BODY                                                                            Time: 10:11:26  
____________________________________________________________________________________________________________________________________
         B6C3F1 MICE FEMALE                        CONTROL      0.3          1.0          3.0                                       
                                                                MG/M3        MG/M3        MG/M3                                     
____________________________________________________________________________________________________________________________________
                                                                                                                                    
RESPIRATORY SYSTEM - CONT                                                                                                           
      Olfactory Epithelium, Atrophy                                 2 (4%)      12 (24%)     46 (96%)                               
      Olfactory Epithelium, Degeneration, Hyaline      3 (6%)       1 (2%)       2 (4%)       2 (4%)                                
      Olfactory Epithelium, Hyperplasia                                                      30 (63%)                               
      Olfactory Epithelium, Metaplasia                              1 (2%)       1 (2%)                                             
      Respiratory Epithelium, Degeneration, Hyaline   20 (40%)     16 (32%)     14 (29%)     11 (23%)                               
      Respiratory Epithelium, Metaplasia, Squamous                                            4 (8%)                                
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 SPECIAL SENSES SYSTEM                                                                                                              
                                                                                                                                    
   Eye                                                (1)                                                                           
      Degeneration                                     1 (100%)                                                                     
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 URINARY SYSTEM                                                                                                                     
                                                                                                                                    
   Kidney                                             (50)         (50)         (50)         (50)                                   
      Cyst                                             1 (2%)                                 2 (4%)                                
      Infarct                                                                                 1 (2%)                                
      Infiltration Cellular, Mixed Cell                3 (6%)       1 (2%)       1 (2%)       3 (6%)                                
      Inflammation, Chronic                                         1 (2%)       1 (2%)                                             
      Metaplasia, Osseous                                           1 (2%)       1 (2%)                                             
      Mineralization                                                                          1 (2%)                                
      Nephropathy                                      5 (10%)      6 (12%)      7 (14%)      3 (6%)                                
      Pigmentation, Hemosiderin                                                               1 (2%)                                
   Urinary Bladder                                    (48)         (47)         (45)         (46)                                   
      Edema                                                         1 (2%)                                                          
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    6                                                              
NTP Experiment-Test: 05156-06         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                    COBALT SULFATE HEPTAHYDRATE                                Date: 07/03/96  
Route: RESPIRATORY EXPOSURE WHOLE BODY                                                                            Time: 10:11:26  
____________________________________________________________________________________________________________________________________
         B6C3F1 MICE MALE                          CONTROL      0.3          1.0          3.0                                       
                                                                MG/M3        MG/M3        MG/M3                                     
____________________________________________________________________________________________________________________________________
DISPOSITION SUMMARY                                                                                                                 
  Animals Initially In Study                          50           50           50           50                                     
  Early Deaths                                                                                                                      
    Moribund Sacrifice                                19           16           17           23                                     
    Accidently Killed                                  1                                      1                                     
    Natural Death                                      8            3            9            6                                     
  Survivors                                                                                                                         
    Terminal Sacrifice                                22           31           24           20                                     
  Animals Examined Microscopically                    50           50           50           50                                     
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 ALIMENTARY SYSTEM                                                                                                                  
                                                                                                                                    
   Gallbladder                                        (37)         (41)         (38)         (38)                                   
      Degeneration, Hyaline                            1 (3%)       1 (2%)       2 (5%)                                             
      Infiltration Cellular, Lymphocyte                                          1 (3%)                                             
   Intestine Small, Duodenum                          (45)         (49)         (42)         (45)                                   
      Hyperplasia, Lymphoid                                                      1 (2%)                                             
      Inflammation, Chronic                                                      1 (2%)                                             
      Necrosis, Focal                                                            1 (2%)                                             
   Liver                                              (50)         (50)         (50)         (50)                                   
      Basophilic Focus                                 1 (2%)                                                                       
      Clear Cell Focus                                              3 (6%)       2 (4%)                                             
      Clear Cell Focus, Multiple                                                 1 (2%)                                             
      Cyst                                                                                    1 (2%)                                
      Eosinophilic Focus                               8 (16%)      7 (14%)      9 (18%)      2 (4%)                                
      Eosinophilic Focus, Multiple                     1 (2%)       1 (2%)       3 (6%)                                             
      Infiltration Cellular, Lymphocyte                1 (2%)                                                                       
      Inflammation, Chronic                           33 (66%)     36 (72%)     40 (80%)     39 (78%)                               
      Karyomegaly                                     39 (78%)     35 (70%)     39 (78%)     43 (86%)                               
      Mineralization                                   1 (2%)                                                                       
      Mitotic Alteration                                                                      1 (2%)                                
      Necrosis, Focal                                  3 (6%)       3 (6%)       6 (12%)      1 (2%)                                
      Regeneration                                    32 (64%)     30 (60%)     35 (70%)     38 (76%)                               
      Vacuolization Cytoplasmic, Diffuse                            3 (6%)       1 (2%)                                             
      Vacuolization Cytoplasmic, Focal                                           1 (2%)                                             
      Bile Duct, Hyperplasia                                        3 (6%)       6 (12%)      4 (8%)                                
      Oval Cell, Hyperplasia                          38 (76%)     36 (72%)     40 (80%)     44 (88%)                               
   Mesentery                                          (3)          (4)          (5)          (4)                                    
      Inflammation, Chronic                            1 (33%)                                1 (25%)                               
      Mineralization                                                             1 (20%)                                            
      Artery, Fibrosis                                 1 (33%)                                1 (25%)                               
      Artery, Inflammation, Chronic                                 1 (25%)                                                         
      Fat, Necrosis                                    1 (33%)      2 (50%)      3 (60%)                                            
   Pancreas                                           (48)         (50)         (49)         (50)                                   
      Acinus, Atrophy                                               1 (2%)                                                          
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    7                                                              
NTP Experiment-Test: 05156-06         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                    COBALT SULFATE HEPTAHYDRATE                                Date: 07/03/96  
Route: RESPIRATORY EXPOSURE WHOLE BODY                                                                            Time: 10:11:26  
____________________________________________________________________________________________________________________________________
         B6C3F1 MICE MALE                          CONTROL      0.3          1.0          3.0                                       
                                                                MG/M3        MG/M3        MG/M3                                     
____________________________________________________________________________________________________________________________________
                                                                                                                                    
ALIMENTARY SYSTEM - CONT                                                                                                            
   Stomach, Forestomach                               (49)         (50)         (50)         (50)                                   
      Cyst                                                                       1 (2%)                                             
      Hyperplasia, Squamous                            4 (8%)       2 (4%)                    2 (4%)                                
      Inflammation                                                                            1 (2%)                                
   Stomach, Glandular                                 (48)         (50)         (50)         (50)                                   
      Mineralization                                                                          1 (2%)                                
   Tooth                                                                                     (1)                                    
      Inflammation                                                                            1 (100%)                              
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 CARDIOVASCULAR SYSTEM                                                                                                              
                                                                                                                                    
   Heart                                              (50)         (50)         (50)         (50)                                   
      Cardiomyopathy                                   1 (2%)       4 (8%)       2 (4%)       1 (2%)                                
      Inflammation, Chronic                                                      1 (2%)                                             
      Artery, Inflammation, Chronic                                              1 (2%)                                             
      Atrium, Thrombosis                               1 (2%)       2 (4%)       3 (6%)       2 (4%)                                
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 ENDOCRINE SYSTEM                                                                                                                   
                                                                                                                                    
   Adrenal Cortex                                     (49)         (50)         (49)         (50)                                   
      Accessory Adrenal Cortical Nodule                                          1 (2%)                                             
      Hyperplasia                                      3 (6%)       4 (8%)       5 (10%)      2 (4%)                                
      Inflammation                                                  1 (2%)                                                          
      Necrosis                                                      1 (2%)                                                          
      Necrosis, Diffuse                                                          1 (2%)                                             
   Adrenal Medulla                                    (48)         (50)         (49)         (50)                                   
      Hyperplasia                                      1 (2%)                                 5 (10%)                               
      Necrosis, Diffuse                                                          1 (2%)                                             
   Thyroid Gland                                      (49)         (50)         (50)         (50)                                   
      Inflammation                                                                            1 (2%)                                
      Follicular Cell, Hyperplasia                     3 (6%)      17 (34%)     11 (22%)     10 (20%)                               
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 GENERAL BODY SYSTEM                                                                                                                
                                                                                                                                    
   Tissue NOS                                         (1)                       (1)                                                 
      Inflammation, Chronic                                                      1 (100%)                                           
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 GENITAL SYSTEM                                                                                                                     
                                                                                                                                    
   Epididymis                                         (49)         (50)         (50)         (50)                                   
      Degeneration                                                                            1 (2%)                                
      Granuloma Sperm                                  1 (2%)                                                                       
      Inflammation, Chronic                                                      1 (2%)       2 (4%)                                
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    8                                                              
NTP Experiment-Test: 05156-06         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                    COBALT SULFATE HEPTAHYDRATE                                Date: 07/03/96  
Route: RESPIRATORY EXPOSURE WHOLE BODY                                                                            Time: 10:11:26  
____________________________________________________________________________________________________________________________________
         B6C3F1 MICE MALE                          CONTROL      0.3          1.0          3.0                                       
                                                                MG/M3        MG/M3        MG/M3                                     
____________________________________________________________________________________________________________________________________
                                                                                                                                    
GENITAL SYSTEM - CONT                                                                                                               
      Mineralization                                                2 (4%)       1 (2%)                                             
   Penis                                              (1)                                                                           
      Inflammation, Chronic                            1 (100%)                                                                     
   Preputial Gland                                    (49)         (50)         (50)         (49)                                   
      Cyst                                             1 (2%)       2 (4%)       3 (6%)       1 (2%)                                
      Inflammation, Chronic                           13 (27%)     12 (24%)      9 (18%)      5 (10%)                               
      Inflammation, Suppurative                                     2 (4%)       2 (4%)                                             
   Prostate                                           (46)         (50)         (44)         (49)                                   
      Inflammation                                     2 (4%)                    2 (5%)       1 (2%)                                
   Seminal Vesicle                                    (48)         (50)         (49)         (49)                                   
      Inflammation, Chronic                                                      1 (2%)                                             
   Testes                                             (49)         (50)         (50)         (50)                                   
      Atrophy                                                       2 (4%)                    2 (4%)                                
      Degeneration, Focal                                                        1 (2%)                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 HEMATOPOIETIC SYSTEM                                                                                                               
                                                                                                                                    
   Lymph Node                                         (1)          (1)          (2)          (2)                                    
      Iliac, Hyperplasia, Lymphoid                                  1 (100%)                  1 (50%)                               
      Iliac, Infiltration Cellular, Histiocyte                                   1 (50%)                                            
      Renal, Hyperplasia, Lymphoid                                  1 (100%)                                                        
   Lymph Node, Bronchial                              (21)         (24)         (28)         (25)                                   
      Infiltration Cellular, Plasma Cell                            1 (4%)                                                          
      Infiltration Cellular, Histiocyte                1 (5%)                                 1 (4%)                                
   Lymph Node, Mesenteric                             (49)         (48)         (43)         (47)                                   
      Hematopoietic Cell Proliferation                                           1 (2%)                                             
      Hemorrhage                                       2 (4%)       2 (4%)       4 (9%)       3 (6%)                                
      Hyperplasia, Lymphoid                                         1 (2%)                    2 (4%)                                
      Inflammation, Chronic                            1 (2%)                    2 (5%)       2 (4%)                                
   Lymph Node, Mediastinal                            (43)         (28)         (31)         (35)                                   
      Hyperplasia, Lymphoid                                         1 (4%)       4 (13%)                                            
      Infiltration Cellular, Plasma Cell               1 (2%)       1 (4%)                                                          
      Infiltration Cellular, Histiocyte                2 (5%)                    1 (3%)                                             
      Inflammation, Chronic                                                      1 (3%)       1 (3%)                                
   Spleen                                             (47)         (50)         (49)         (50)                                   
      Angiectasis                                      1 (2%)                                 1 (2%)                                
      Hematopoietic Cell Proliferation                10 (21%)      6 (12%)      6 (12%)     14 (28%)                               
      Hyperplasia, Lymphoid                                         4 (8%)                    1 (2%)                                
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 INTEGUMENTARY SYSTEM                                                                                                               
                                                                                                                                    
   Skin                                               (49)         (50)         (49)         (49)                                   
      Inflammation, Chronic                                         1 (2%)                    2 (4%)                                
      Inflammation, Suppurative                                     1 (2%)                                                          
      Ulcer                                                         1 (2%)       2 (4%)                                             
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    9                                                              
NTP Experiment-Test: 05156-06         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                    COBALT SULFATE HEPTAHYDRATE                                Date: 07/03/96  
Route: RESPIRATORY EXPOSURE WHOLE BODY                                                                            Time: 10:11:26  
____________________________________________________________________________________________________________________________________
         B6C3F1 MICE MALE                          CONTROL      0.3          1.0          3.0                                       
                                                                MG/M3        MG/M3        MG/M3                                     
____________________________________________________________________________________________________________________________________
                                                                                                                                    
INTEGUMENTARY SYSTEM - CONT                                                                                                         
      Epidermis, Hyperplasia                                                     1 (2%)       1 (2%)                                
      Prepuce, Inflammation, Chronic                                1 (2%)                                                          
      Prepuce, Ulcer                                   4 (8%)       1 (2%)       1 (2%)                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 MUSCULOSKELETAL SYSTEM                                                                                                             
                                                                                                                                    
   Bone                                               (50)         (50)         (50)         (50)                                   
      Fracture                                                                                1 (2%)                                
   Skeletal Muscle                                    (1)                                    (2)                                    
      Inflammation, Chronic, Focal                                                            1 (50%)                               
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 NERVOUS SYSTEM                                                                                                                     
                                                                                                                                    
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 RESPIRATORY SYSTEM                                                                                                                 
                                                                                                                                    
   Larynx                                             (48)         (49)         (48)         (49)                                   
      Foreign Body                                     1 (2%)                                                                       
      Metaplasia, Squamous                                         37 (76%)     48 (100%)    44 (90%)                               
   Lung                                               (50)         (50)         (50)         (50)                                   
      Hemorrhage                                       1 (2%)                    1 (2%)       1 (2%)                                
      Infiltration Cellular, Diffuse, Histiocyte       1 (2%)       2 (4%)       4 (8%)      10 (20%)                               
      Infiltration Cellular, Focal, Histiocyte        10 (20%)      5 (10%)      8 (16%)     17 (34%)                               
      Inflammation, Chronic                                         1 (2%)       1 (2%)       3 (6%)                                
      Alveolar Epithelium, Hyperplasia                              4 (8%)       4 (8%)       4 (8%)                                
      Alveolar Epithelium, Goblet Cell, Metaplasia,                                                                                 
           Focal                                                    1 (2%)                                                          
      Artery, Thrombosis                                                         1 (2%)                                             
      Bronchus, Hyperplasia                                                      1 (2%)                                             
      Bronchus, Vacuolization Cytoplasmic                          18 (36%)     34 (68%)     38 (76%)                               
   Nose                                               (50)         (50)         (48)         (49)                                   
      Hemorrhage                                                                              1 (2%)                                
      Inflammation, Suppurative                                     1 (2%)                    6 (12%)                               
      Olfactory Epithelium, Atrophy                                             29 (60%)     48 (98%)                               
      Olfactory Epithelium, Degeneration, Hyaline                                2 (4%)       2 (4%)                                
      Olfactory Epithelium, Hyperplasia                                                      10 (20%)                               
      Olfactory Epithelium, Metaplasia                                                        2 (4%)                                
      Respiratory Epithelium, Degeneration, Hyaline                                           1 (2%)                                
   Trachea                                            (49)         (50)         (50)         (50)                                   
      Inflammation, Chronic                            1 (2%)                                                                       
____________________________________________________________________________________________________________________________________
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page   10                                                              
NTP Experiment-Test: 05156-06         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                    COBALT SULFATE HEPTAHYDRATE                                Date: 07/03/96  
Route: RESPIRATORY EXPOSURE WHOLE BODY                                                                            Time: 10:11:26  
____________________________________________________________________________________________________________________________________
         B6C3F1 MICE MALE                          CONTROL      0.3          1.0          3.0                                       
                                                                MG/M3        MG/M3        MG/M3                                     
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 SPECIAL SENSES SYSTEM                                                                                                              
                                                                                                                                    
   Eye                                                (1)                       (1)          (1)                                    
      Degeneration                                     1 (100%)                               1 (100%)                              
      Hemorrhage                                                                              1 (100%)                              
      Inflammation                                                                            1 (100%)                              
      Cornea, Inflammation                                                       1 (100%)                                           
   Harderian Gland                                    (4)          (4)          (4)          (6)                                    
      Inflammation, Acute                                           1 (25%)                                                         
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 URINARY SYSTEM                                                                                                                     
                                                                                                                                    
   Kidney                                             (49)         (50)         (50)         (50)                                   
      Cyst                                                          1 (2%)                    1 (2%)                                
      Infiltration Cellular, Mixed Cell                5 (10%)      1 (2%)       5 (10%)      3 (6%)                                
      Inflammation, Chronic                            1 (2%)                    1 (2%)                                             
      Metaplasia, Osseous                                                        1 (2%)                                             
      Mineralization                                                                          1 (2%)                                
      Nephropathy                                     11 (22%)     13 (26%)      7 (14%)      9 (18%)                               
      Glomerulus, Amyloid Deposition                                1 (2%)                    2 (4%)                                
      Medulla, Inflammation, Chronic                                                          1 (2%)                                
      Renal Tubule, Hyperplasia                                                               1 (2%)                                
   Urinary Bladder                                    (46)         (49)         (45)         (48)                                   
      Inflammation                                     3 (7%)                    3 (7%)       3 (6%)                                
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page   11                                                              
                             ------------------------------------------------------------                                           
                             ----------              END OF REPORT             ----------                                           
                             ------------------------------------------------------------